Atlantic American Corp 10-Q for FY2020 Q3
Atlantic American Corp (AAME)
10-Q
2020-11-10
For: 2020-09-30
View Original
Added on
April 09, 2026
About this 10-Q
Atlantic American Corp filed this 10-Q on November 10, 2020, covering the quarter ended September 30, 2020 (FY2020 Q3).
Headline figures
Quarter ended September 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $46.27M
- down 3.1% from $47.75M a year earlier
- Net income
- $1.88M
- compared with a net loss of $1.39M a year earlier
- Diluted EPS
- $0.09
- compared with -$0.07 a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
| ☑ |
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended September 30, 2020
or
| ☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Commission File Number 0-3722
ATLANTIC AMERICAN CORPORATION
(Exact name of registrant as specified in its charter)
|
Georgia
|
58-1027114
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
4370 Peachtree Road, N.E.,
Atlanta, Georgia
|
30319
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
(404) 266-5500
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||
|
Common Stock, par value $1.00 per share
|
AAME
|
NASDAQ Global Market
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that
the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12
months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large
accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☑ Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to
Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑
The total number of shares of the registrant’s Common Stock, $1 par value, outstanding on October 22, 2020 was 20,414,279.
ATLANTIC AMERICAN CORPORATION
|
Part I.
|
Financial Information
|
|
|
Item 1.
|
2
|
|
|
2
|
||
|
3
|
||
|
4
|
||
|
5
|
||
|
6
|
||
|
7
|
||
|
Item 2.
|
18
|
|
|
Item 4.
|
24
|
|
|
Part II.
|
Other Information
|
|
|
Item 2.
|
25
|
|
|
Item 6.
|
25
|
|
|
26
|
PART I.
FINANCIAL INFORMATION
ATLANTIC AMERICAN CORPORATION
(Dollars in thousands, except share data)
|
Unaudited
September 30,
2020
|
December 31,
2019
|
|||||||
|
ASSETS
|
||||||||
|
Cash and cash equivalents
|
$
|
8,940
|
$
|
12,893
|
||||
|
Investments:
|
||||||||
|
Fixed maturities, available-for-sale, at fair value (amortized cost: $222,969 and $219,233)
|
247,997
|
232,472
|
||||||
|
Equity securities, at fair value (cost: $6,400 and $7,168)
|
14,323
|
22,922
|
||||||
|
Other invested assets (cost: $9,908 and $9,908)
|
9,097
|
9,960
|
||||||
|
Policy loans
|
1,964
|
2,007
|
||||||
|
Real estate
|
38
|
38
|
||||||
|
Investment in unconsolidated trusts
|
1,238
|
1,238
|
||||||
|
Total investments
|
274,657
|
268,637
|
||||||
|
Receivables:
|
||||||||
|
Reinsurance
|
29,961
|
32,135
|
||||||
|
Insurance premiums and other (net of allowance for doubtful accounts: $198 and $183)
|
20,039
|
13,134
|
||||||
|
Deferred income taxes, net
|
679
|
314
|
||||||
|
Deferred acquisition costs
|
39,769
|
38,861
|
||||||
|
Other assets
|
8,363
|
9,108
|
||||||
|
Intangibles
|
2,544
|
2,544
|
||||||
|
Total assets
|
$
|
384,952
|
$
|
377,626
|
||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
|
Insurance reserves and policyholder funds:
|
||||||||
|
Future policy benefits
|
$
|
91,694
|
$
|
92,490
|
||||
|
Unearned premiums
|
30,198
|
26,035
|
||||||
|
Losses and claims
|
78,157
|
81,448
|
||||||
|
Other policy liabilities
|
1,015
|
1,933
|
||||||
|
Total insurance reserves and policyholder funds
|
201,064
|
201,906
|
||||||
|
Accounts payable and accrued expenses
|
22,135
|
23,588
|
||||||
|
Junior subordinated debenture obligations, net
|
33,738
|
33,738
|
||||||
|
Total liabilities
|
256,937
|
259,232
|
||||||
|
Commitments and contingencies (Note 10)
|
||||||||
|
Shareholders’ equity:
|
||||||||
|
Preferred stock, $1 par, 4,000,000 shares authorized; Series D preferred, 55,000 shares issued and outstanding; $5,500 redemption value
|
55
|
55
|
||||||
|
Common stock, $1 par, 50,000,000 shares authorized; shares issued: 22,400,894; shares outstanding: 20,414,279 and 20,472,162
|
22,401
|
22,401
|
||||||
|
Additional paid-in capital
|
57,436
|
57,820
|
||||||
|
Retained earnings
|
36,042
|
36,020
|
||||||
|
Accumulated other comprehensive income
|
19,772
|
10,459
|
||||||
|
Unearned stock grant compensation
|
(350
|
)
|
(781
|
)
|
||||
|
Treasury stock, at cost: 1,986,615 and 1,928,732 shares
|
(7,341
|
)
|
(7,580
|
)
|
||||
|
Total shareholders’ equity
|
128,015
|
118,394
|
||||||
|
Total liabilities and shareholders’ equity
|
$
|
384,952
|
$
|
377,626
|
||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
ATLANTIC AMERICAN CORPORATION
(Unaudited; Dollars in thousands, except per share data)
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Revenue:
|
||||||||||||||||
|
Insurance premiums, net
|
$
|
44,978
|
$
|
45,005
|
$
|
137,027
|
$
|
135,256
|
||||||||
|
Net investment income
|
1,828
|
2,187
|
5,717
|
6,834
|
||||||||||||
|
Realized investment gains (losses), net
|
183
|
(430
|
)
|
432
|
1,565
|
|||||||||||
|
Unrealized gains (losses) on equity securities, net
|
(731
|
)
|
944
|
(7,831
|
)
|
2,096
|
||||||||||
|
Other income
|
11
|
39
|
71
|
139
|
||||||||||||
|
Total revenue
|
46,269
|
47,745
|
135,416
|
145,890
|
||||||||||||
|
Benefits and expenses:
|
||||||||||||||||
|
Insurance benefits and losses incurred
|
29,219
|
34,719
|
89,878
|
104,177
|
||||||||||||
|
Commissions and underwriting expenses
|
11,202
|
11,471
|
34,682
|
33,995
|
||||||||||||
|
Interest expense
|
363
|
533
|
1,253
|
1,624
|
||||||||||||
|
Other expense
|
3,052
|
2,766
|
9,116
|
8,142
|
||||||||||||
|
Total benefits and expenses
|
43,836
|
49,489
|
134,929
|
147,938
|
||||||||||||
|
Income (loss) before income taxes
|
2,433
|
(1,744
|
)
|
487
|
(2,048
|
)
|
||||||||||
|
Income tax expense (benefit)
|
557
|
(352
|
)
|
166
|
(392
|
)
|
||||||||||
|
Net income (loss)
|
1,876
|
(1,392
|
)
|
321
|
(1,656
|
)
|
||||||||||
|
Preferred stock dividends
|
(100
|
)
|
(100
|
)
|
(299
|
)
|
(299
|
)
|
||||||||
|
Net income (loss) applicable to common shareholders
|
$
|
1,776
|
$
|
(1,492
|
)
|
$
|
22
|
$
|
(1,955
|
)
|
||||||
|
Earnings (loss) per common share (basic)
|
$
|
.09
|
$
|
(.07
|
)
|
$
|
—
|
$
|
(.10
|
)
|
||||||
|
Earnings (loss) per common share (diluted)
|
$
|
.09
|
$
|
(.07
|
)
|
$
|
—
|
$
|
(.10
|
)
|
||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
ATLANTIC AMERICAN CORPORATION
(Unaudited; Dollars in thousands)
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Net income (loss)
|
$
|
1,876
|
$
|
(1,392
|
)
|
$
|
321
|
$
|
(1,656
|
)
|
||||||
|
Other comprehensive income:
|
||||||||||||||||
|
Available-for-sale fixed maturity securities:
|
||||||||||||||||
|
Gross unrealized holding gain arising in the period
|
3,016
|
5,871
|
12,133
|
22,275
|
||||||||||||
|
Related income tax effect
|
(633
|
)
|
(1,232
|
)
|
(2,548
|
)
|
(4,677
|
)
|
||||||||
|
Subtotal
|
2,383
|
4,639
|
9,585
|
17,598
|
||||||||||||
|
Less: reclassification adjustment for net realized gains (losses) included in net income (loss)
|
(95
|
)
|
538
|
(344
|
)
|
(344
|
)
|
|||||||||
|
Related income tax effect
|
20
|
(113
|
)
|
72
|
72
|
|||||||||||
|
Subtotal
|
(75
|
)
|
425
|
(272
|
)
|
(272
|
)
|
|||||||||
|
Total other comprehensive income, net of tax
|
2,308
|
5,064
|
9,313
|
17,326
|
||||||||||||
|
Total comprehensive income
|
$
|
4,184
|
$
|
3,672
|
$
|
9,634
|
$
|
15,670
|
||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
ATLANTIC AMERICAN CORPORATION
(Unaudited; Dollars in thousands except share data)
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Preferred stock:
|
||||||||||||||||
|
Balance, beginning of period
|
$
|
55
|
$
|
55
|
$
|
55
|
$
|
55
|
||||||||
|
Balance, end of period
|
55
|
55
|
55
|
55
|
||||||||||||
|
Common stock:
|
||||||||||||||||
|
Balance, beginning of period
|
22,401
|
22,401
|
22,401
|
22,401
|
||||||||||||
|
Balance, end of period
|
22,401
|
22,401
|
22,401
|
22,401
|
||||||||||||
|
Additional paid-in capital:
|
||||||||||||||||
|
Balance, beginning of period
|
57,435
|
57,444
|
57,820
|
57,414
|
||||||||||||
|
Restricted stock grants, net of forfeitures
|
—
|
372
|
(377
|
)
|
396
|
|||||||||||
|
Issuance of shares under stock plans
|
1
|
3
|
(7
|
)
|
9
|
|||||||||||
|
Balance, end of period
|
57,436
|
57,819
|
57,436
|
57,819
|
||||||||||||
|
Retained earnings:
|
||||||||||||||||
|
Balance, beginning of period
|
34,266
|
36,342
|
36,020
|
37,208
|
||||||||||||
|
Net income (loss)
|
1,876
|
(1,392
|
)
|
321
|
(1,656
|
)
|
||||||||||
|
Dividends on common stock
|
—
|
—
|
—
|
(403
|
)
|
|||||||||||
|
Dividends accrued on preferred stock
|
(100
|
)
|
(100
|
)
|
(299
|
)
|
(299
|
)
|
||||||||
|
Balance, end of period
|
36,042
|
34,850
|
36,042
|
34,850
|
||||||||||||
|
Accumulated other comprehensive income (loss):
|
||||||||||||||||
|
Balance, beginning of period
|
17,464
|
4,727
|
10,459
|
(7,535
|
)
|
|||||||||||
|
Other comprehensive income, net of tax
|
2,308
|
5,064
|
9,313
|
17,326
|
||||||||||||
|
Balance, end of period
|
19,772
|
9,791
|
19,772
|
9,791
|
||||||||||||
|
Unearned Stock Grant Compensation:
|
||||||||||||||||
|
Balance, beginning of period
|
(466
|
)
|
(150
|
)
|
(781
|
)
|
(186
|
)
|
||||||||
|
Restricted stock grants, net of forfeitures
|
—
|
(877
|
)
|
61
|
(948
|
)
|
||||||||||
|
Amortization of unearned compensation
|
116
|
84
|
370
|
191
|
||||||||||||
|
Balance, end of period
|
(350
|
)
|
(943
|
)
|
(350
|
)
|
(943
|
)
|
||||||||
|
Treasury Stock:
|
||||||||||||||||
|
Balance, beginning of period
|
(7,261
|
)
|
(8,049
|
)
|
(7,580
|
)
|
(7,985
|
)
|
||||||||
|
Restricted stock grants, net of forfeitures
|
—
|
505
|
316
|
552
|
||||||||||||
|
Purchase of 0 and 26,210 shares, as of 2020 and 2019, respectively, for treasury
|
—
|
—
|
—
|
(71
|
)
|
|||||||||||
|
Net shares acquired related to employee share-based compensation plans
|
(81
|
)
|
(23
|
)
|
(91
|
)
|
(72
|
)
|
||||||||
|
Issuance of shares under stock plans
|
1
|
5
|
14
|
14
|
||||||||||||
|
Balance, end of period
|
(7,341
|
)
|
(7,562
|
)
|
(7,341
|
)
|
(7,562
|
)
|
||||||||
|
Total shareholders’ equity
|
$
|
128,015
|
$
|
116,411
|
$
|
128,015
|
$
|
116,411
|
||||||||
|
Dividends declared on common stock per share
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
(.02
|
)
|
|||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
ATLANTIC AMERICAN CORPORATION
(Unaudited; Dollars in thousands)
|
Nine Months Ended
September 30,
|
||||||||
|
2020
|
2019
|
|||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
|
Net income (loss)
|
$
|
321
|
$
|
(1,656
|
)
|
|||
|
Adjustments to reconcile income (loss) to net cash used in operating activities:
|
||||||||
|
Additions to acquisition costs, net
|
(908
|
)
|
(1,707
|
)
|
||||
|
Realized investment gains, net
|
(432
|
)
|
(1,565
|
)
|
||||
|
Unrealized losses (gains) on equity securities, net
|
7,831
|
(2,096
|
)
|
|||||
|
Distributions received from equity method investees
|
—
|
379
|
||||||
|
Compensation expense related to share awards
|
370
|
191
|
||||||
|
Depreciation and amortization
|
772
|
588
|
||||||
|
Deferred income tax benefit
|
(2,841
|
)
|
(596
|
)
|
||||
|
Increase in receivables, net
|
(4,731
|
)
|
(7,917
|
)
|
||||
|
(Decrease) increase in insurance reserves and policyholder funds
|
(842
|
)
|
9,276
|
|||||
|
(Decrease) increase in accounts payable and accrued expenses
|
(1,752
|
)
|
3,271
|
|||||
|
Other, net
|
1,308
|
(5,738
|
)
|
|||||
|
Net cash used in operating activities
|
(904
|
)
|
(7,570
|
)
|
||||
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
|
Proceeds from investments sold
|
8,916
|
119,929
|
||||||
|
Proceeds from investments matured, called or redeemed
|
5,584
|
5,907
|
||||||
|
Investments purchased
|
(17,277
|
)
|
(94,316
|
)
|
||||
|
Additions to property and equipment
|
(188
|
)
|
(44
|
)
|
||||
|
Net cash (used in) provided by investing activities
|
(2,965
|
)
|
31,476
|
|||||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
|
Payment of dividends on common stock
|
—
|
(403
|
)
|
|||||
|
Proceeds from shares issued under stock plans
|
7
|
23
|
||||||
|
Treasury stock acquired — share repurchase authorization
|
—
|
(71
|
)
|
|||||
|
Treasury stock acquired — net employee share-based compensation
|
(91
|
)
|
(72
|
)
|
||||
|
Net cash used in financing activities
|
(84
|
)
|
(523
|
)
|
||||
|
Net (decrease) increase in cash and cash equivalents
|
(3,953
|
)
|
23,383
|
|||||
|
Cash and cash equivalents at beginning of period
|
12,893
|
12,630
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
8,940
|
$
|
36,013
|
||||
|
SUPPLEMENTAL CASH FLOW INFORMATION:
|
||||||||
|
Cash paid for interest
|
$
|
1,309
|
$
|
1,644
|
||||
|
Cash paid for income taxes
|
$
|
3,310
|
$
|
1,625
|
||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
ATLANTIC AMERICAN CORPORATION
(Unaudited; Dollars in thousands, except per share amounts)
| Note 1. |
Basis of Presentation
|
The accompanying unaudited condensed consolidated financial statements include the accounts of Atlantic American Corporation (the “Parent”) and its subsidiaries (collectively with the Parent, the
“Company”). The Parent’s primary operating subsidiaries, American Southern Insurance Company and American Safety Insurance Company (together known as “American Southern”) and Bankers Fidelity Life Insurance Company and Bankers Fidelity Assurance
Company (together known as “Bankers Fidelity”), operate in two principal business units. American Southern operates in the property and casualty insurance market, while Bankers Fidelity operates in the life and health insurance market. All
significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”)
for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for audited annual financial statements. In the opinion of
management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. The unaudited condensed consolidated financial statements included herein and these related notes should be
read in conjunction with the Company’s consolidated financial statements, and the notes thereto, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 (the “2019 Annual Report”). The Company’s financial condition
and results of operations and cash flows as of and for the three month and nine month periods ended September 30, 2020 are not necessarily indicative of the financial condition or results of operations and cash flows that may be expected for the year
ending December 31, 2020 or for any other future period.
The Company’s significant accounting policies have not changed materially from those set out in the 2019 Annual Report, except as noted below for the adoption of new accounting standards.
The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosures of
contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.
On March 11, 2020, the World Health Organization declared the Novel Coronavirus (“COVID-19”) outbreak a global pandemic. The impact of COVID-19 and related actions to attempt to control its spread
began to impact the Company’s business operations in March 2020, and we expect that the pandemic, actions that have been or will be taken in response to it and its overall impact on the economy, will continue to have an effect on our business
operations and our operating results. The Company’s insurance subsidiaries may experience difficulties collecting premiums from some policyholders, and policyholders with financial difficulties may decide not to renew insurance policies with the
Company. Although it cannot be predicted with certainty at this time, the Company’s insurance subsidiaries do not expect a direct material impact from the outbreak of COVID-19 in terms of increased claims and losses, but that may change as more
information becomes available. In addition, economic uncertainty related to COVID-19 has led to, and may continue to create, increased volatility in the investment markets. The impact of COVID-19 on the economy and on the Company continues to
evolve and its future effects are uncertain. The Company continues to monitor the effects and risks of COVID-19 to assess its impact on the Company’s business, financial condition, results of operations, liquidity and capital position.
On March 27, 2020, Congress passed the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), which is intended to provide fast and direct economic assistance for American workers and
families, small businesses, and to preserve jobs in American industries. The CARES Act includes, among other things, provisions relating to payroll tax credits and deferrals, net operating loss carryback periods, alternative minimum tax credits and
technical corrections to tax depreciation methods for qualified improvement property. The Company does not qualify as a small business under the CARES Act and therefore did not apply for any of the government loan programs; however, the Company
intends to monitor and assess the availability of resources and other benefits that might be available to the Company under the CARES Act and through other programs.
| Note 2. |
Recently Issued Accounting Standards
|
Adoption of New Accounting Standards
Fair Value Measurement – Changes to the Disclosure Requirements for Fair Value Measurement. In August 2018, the Financial Accounting Standards Board (“FASB”)
issued Accounting Standards Update (“ASU”) 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”). This guidance removes the following disclosure
requirements from Topic 820: (1) the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, (2) the policy for timing of transfers between levels, and (3) the valuation processes for Level 3 fair value
measurements. This disclosure also includes the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and
weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The Company adopted ASU 2018-13 as of January 1, 2020. The adoption of this ASU did not have an impact on the Company’s consolidated financial
statements.
Goodwill. In January 2017, the FASB issued ASU No. 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (“ASU
2017-04”). ASU 2017-04 is intended to simplify the evaluation of goodwill. The updated guidance requires recognition and measurement of goodwill impairment based on the excess of the carrying value of the reporting unit compared to its estimated
fair value, with the amount of the impairment not to exceed the carrying value of the reporting unit’s goodwill. Under the prior accounting guidance, if the reporting unit’s carrying value exceeds its estimated fair value, the Company allocates the
fair value of the reporting unit to all of the assets and liabilities of the reporting unit to determine an implied goodwill value. An impairment loss is then recognized for the excess, if any, of the carrying value of the reporting unit’s goodwill
compared to the implied goodwill value. The Company adopted ASU 2017-04 as of January 1, 2020. The adoption of this ASU did not have an impact on the Company’s consolidated financial statements.
Future Adoption of New Accounting Standards
Reference Rate Reform. In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform
on Financial Reporting (“ASU 2020-04”). This guidance provides optional expedients and exceptions for applying GAAP to investments, derivatives, or other transactions that reference the London Interbank Offered Rate (LIBOR) or another reference rate
expected to be discontinued because of reference rate reform. Along with the optional expedients, the amendments include a general principle that permits an entity to consider contract modifications due to reference reform to be an event that does
not require contract re-measurement at the modification date or reassessment of a previous accounting determination. Additionally, a company may make a one-time election to sell, transfer, or both sell and transfer debt securities classified as held
to maturity that reference a rate affected by reference rate reform and that were classified as held to maturity before January 1, 2020. This standard may be elected over time through December 31, 2022 as reference rate reform activities occur. The
Company is currently assessing the effect of adopting this guidance on its financial condition and results of operations.
Investments – Equity Securities. In January 2020, the FASB issued ASU No. 2020-01 (“ASU 2020-01”) Investments-Equity Securities (Topic 321), Investments-Equity
Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) Clarifying the Interactions between Topic 321, Topic 323, and Topic 815. This update, among others, clarifies the interaction of the accounting for equity securities under
Topic 321 and investments under the equity method of accounting in Topic 323 when there is a change in level of ownership or degree of influence. ASU 2020-01 is effective for the Company beginning with the first quarter of 2021 and will be applied
prospectively. Early adoption is permitted. This guidance is not expected to have a material impact on the Company’s consolidated financial statements.
For more information regarding other accounting standards that the Company has not yet adopted, see the “Recently Issued Accounting Standards - Future Adoption of New Accounting Standards” section of
Note 1 of Notes to Consolidated Financial Statements in the 2019 Annual Report.
| Note 3. |
Investments
|
The following tables set forth the estimated fair value, gross unrealized gains, gross unrealized losses and cost or amortized cost of the Company’s investments in fixed maturities and equity
securities, aggregated by type and industry, as of September 30, 2020 and December 31, 2019.
Fixed maturities were comprised of the following:
|
September 30, 2020
|
||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Cost or
Amortized
Cost
|
|||||||||||||
|
Fixed maturities:
|
||||||||||||||||
|
Bonds:
|
||||||||||||||||
|
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
21,039
|
$
|
1,598
|
$
|
21
|
$
|
19,462
|
||||||||
|
Obligations of states and political subdivisions
|
11,752
|
845
|
—
|
10,907
|
||||||||||||
|
Corporate securities:
|
||||||||||||||||
|
Utilities and telecom
|
31,491
|
4,404
|
14
|
27,101
|
||||||||||||
|
Financial services
|
77,366
|
7,573
|
149
|
69,942
|
||||||||||||
|
Other business – diversified
|
45,067
|
4,030
|
960
|
41,997
|
||||||||||||
|
Other consumer – diversified
|
61,032
|
7,903
|
239
|
53,368
|
||||||||||||
|
Total corporate securities
|
214,956
|
23,910
|
1,362
|
192,408
|
||||||||||||
|
Redeemable preferred stocks:
|
||||||||||||||||
|
Other consumer – diversified
|
250
|
58
|
—
|
192
|
||||||||||||
|
Total redeemable preferred stocks
|
250
|
58
|
—
|
192
|
||||||||||||
|
Total fixed maturities
|
$
|
247,997
|
$
|
26,411
|
$
|
1,383
|
$
|
222,969
|
||||||||
|
December 31, 2019
|
||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Cost or
Amortized
Cost
|
|||||||||||||
|
Fixed maturities:
|
||||||||||||||||
|
Bonds:
|
||||||||||||||||
|
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
20,259
|
$
|
467
|
$
|
53
|
$
|
19,845
|
||||||||
|
Obligations of states and political subdivisions
|
11,940
|
371
|
53
|
11,622
|
||||||||||||
|
Corporate securities:
|
||||||||||||||||
|
Utilities and telecom
|
26,648
|
2,404
|
32
|
24,276
|
||||||||||||
|
Financial services
|
73,917
|
4,249
|
57
|
69,725
|
||||||||||||
|
Other business – diversified
|
41,706
|
2,335
|
98
|
39,469
|
||||||||||||
|
Other consumer – diversified
|
57,752
|
3,702
|
54
|
54,104
|
||||||||||||
|
Total corporate securities
|
200,023
|
12,690
|
241
|
187,574
|
||||||||||||
|
Redeemable preferred stocks:
|
||||||||||||||||
|
Other consumer – diversified
|
250
|
58
|
—
|
192
|
||||||||||||
|
Total redeemable preferred stocks
|
250
|
58
|
—
|
192
|
||||||||||||
|
Total fixed maturities
|
$
|
232,472
|
$
|
13,586
|
$
|
347
|
$
|
219,233
|
||||||||
Bonds having an amortized cost of $10,444 and $10,669 and included in the tables above were on deposit with insurance regulatory authorities as of September 30, 2020 and December 31, 2019,
respectively, in accordance with statutory requirements.
Equity securities were comprised of the following:
|
September 30, 2020
|
||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Cost
|
|||||||||||||
|
Equity securities:
|
||||||||||||||||
|
Common and non-redeemable preferred stocks:
|
||||||||||||||||
|
Financial services
|
$
|
2,080
|
$
|
316
|
$
|
3
|
$
|
1,767
|
||||||||
|
Other business – diversified
|
12,243
|
7,610
|
—
|
4,633
|
||||||||||||
|
Total equity securities
|
$
|
14,323
|
$
|
7,926
|
$
|
3
|
$
|
6,400
|
||||||||
|
December 31, 2019
|
||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Cost
|
|||||||||||||
|
Equity securities:
|
||||||||||||||||
|
Common and non-redeemable preferred stocks:
|
||||||||||||||||
|
Financial services
|
$
|
3,159
|
624
|
—
|
2,535
|
|||||||||||
|
Other business – diversified
|
19,763
|
15,130
|
—
|
4,633
|
||||||||||||
|
Total equity securities
|
$
|
22,922
|
$
|
15,754
|
$
|
—
|
$
|
7,168
|
||||||||
The carrying value and amortized cost of the Company’s investments in fixed maturities at September 30, 2020 and December 31, 2019 by contractual maturity were as follows. Actual maturities may
differ from contractual maturities because issuers may call or prepay obligations with or without call or prepayment penalties.
|
September 30, 2020
|
December 31, 2019
|
|||||||||||||||
|
Carrying
Value
|
Amortized
Cost
|
Carrying
Value
|
Amortized
Cost
|
|||||||||||||
|
Due in one year or less
|
$
|
1,040
|
$
|
1,019
|
$
|
—
|
$
|
—
|
||||||||
|
Due after one year through five years
|
20,424
|
19,301
|
14,664
|
14,280
|
||||||||||||
|
Due after five years through ten years
|
94,670
|
86,920
|
77,934
|
73,521
|
||||||||||||
|
Due after ten years
|
122,558
|
106,788
|
130,680
|
122,321
|
||||||||||||
|
Asset backed securities
|
9,305
|
8,941
|
9,194
|
9,111
|
||||||||||||
|
Totals
|
$
|
247,997
|
$
|
222,969
|
$
|
232,472
|
$
|
219,233
|
||||||||
The following tables present the Company’s unrealized loss aging for securities by type and length of time the security was in a continuous unrealized loss position as of September 30, 2020 and
December 31, 2019.
|
September 30, 2020
|
||||||||||||||||||||||||
|
Less than 12 months
|
12 months or longer
|
Total
|
||||||||||||||||||||||
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
|||||||||||||||||||
|
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
2,053
|
$
|
21
|
$
|
—
|
$
|
—
|
$
|
2,053
|
$
|
21
|
||||||||||||
|
Corporate securities
|
19,743
|
1,362
|
—
|
—
|
19,743
|
1,362
|
||||||||||||||||||
|
Total temporarily impaired securities
|
$
|
21,796
|
$
|
1,383
|
$
|
—
|
$
|
—
|
$
|
21,796
|
$
|
1,383
|
||||||||||||
|
December 31, 2019
|
||||||||||||||||||||||||
|
Less than 12 months
|
12 months or longer
|
Total
|
||||||||||||||||||||||
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
|||||||||||||||||||
|
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
3,432
|
$
|
22
|
$
|
3,533
|
$
|
31
|
$
|
6,965
|
$
|
53
|
||||||||||||
|
Obligations of states and political subdivisions
|
3,106
|
53
|
—
|
—
|
3,106
|
53
|
||||||||||||||||||
|
Corporate securities
|
23,245
|
145
|
2,504
|
96
|
25,749
|
241
|
||||||||||||||||||
|
Total temporarily impaired securities
|
$
|
29,783
|
$
|
220
|
$
|
6,037
|
$
|
127
|
$
|
35,820
|
$
|
347
|
||||||||||||
The evaluation for an other than temporary impairment (“OTTI”) is a quantitative and qualitative process, which is subject to risks and uncertainties in the determination of whether declines in the
fair value of investments are other than temporary. Potential risks and uncertainties include, among other things, changes in general economic conditions, an issuer’s financial condition or near term recovery prospects and the effects of changes in
interest rates. In evaluating a potential impairment, the Company considers, among other factors, management’s intent and ability to hold the securities until price recovery, the nature of the investment and the expectation of prospects for the
issuer and its industry, the status of an issuer’s continued satisfaction of its obligations in accordance with their contractual terms, and management’s expectation as to the issuer’s ability and intent to continue to do so, as well as ratings
actions that may affect the issuer’s credit status.
There were no OTTI charges recorded during the three month and nine month periods ended September 30, 2020 and 2019.
As of September 30, 2020 and December 31, 2019, there were twenty and thirty securities, respectively, in an unrealized loss position which primarily included certain of the Company’s investments in
fixed maturities within the financial services, other diversified business and other diversified consumer sectors. The decrease in the number of securities in an unrealized loss position during the nine month period ended September 30, 2020, was
primarily attributable to improvement in market values in certain of the Company’s fixed maturity securities as a result of a declining interest rate environment. The Company does not currently intend to sell nor does it expect to be required to
sell any of the securities in an unrealized loss position. Based upon the Company’s expected continuation of receipt of contractually required principal and interest payments and its intent and ability to retain the securities until price recovery,
as well as the Company’s evaluation of other relevant factors, including those described above, the Company has deemed these securities to be temporarily impaired as of September 30, 2020.
The following tables summarize realized investment gains (losses) for the three month and nine month periods ended September 30, 2020 and 2019.
|
Three Months Ended
September 30, 2020
|
||||||||||||||||
|
Fixed
Maturities
|
Equity
Securities
|
Other
Invested
Assets
|
Total
|
|||||||||||||
|
Gains
|
$
|
95
|
$
|
88
|
$
|
—
|
$
|
183
|
||||||||
|
Losses
|
—
|
—
|
—
|
—
|
||||||||||||
|
Realized investment gains, net
|
$
|
95
|
$
|
88
|
$
|
—
|
$
|
183
|
||||||||
|
Three Months Ended
September 30, 2019
|
||||||||||||||||
|
Fixed
Maturities
|
Equity
Securities
|
Other
Invested
Assets
|
Total
|
|||||||||||||
|
Gains
|
$
|
1,112
|
$
|
108
|
$
|
—
|
$
|
1,220
|
||||||||
|
Losses
|
(1,650
|
)
|
—
|
—
|
(1,650
|
)
|
||||||||||
|
Realized investment gains (losses), net
|
$
|
(538
|
)
|
$
|
108
|
$
|
—
|
$
|
(430
|
)
|
||||||
|
Nine Months Ended
September 30, 2020
|
||||||||||||||||
|
Fixed
Maturities
|
Equity
Securities
|
Other
Invested
Assets
|
Total
|
|||||||||||||
|
Gains
|
$
|
344
|
$
|
88
|
$
|
—
|
$
|
432
|
||||||||
|
Losses
|
—
|
—
|
—
|
—
|
||||||||||||
|
Realized investment gains, net
|
$
|
344
|
$
|
88
|
$
|
—
|
$
|
432
|
||||||||
|
Nine Months Ended
September 30, 2019
|
||||||||||||||||
|
Fixed
Maturities
|
Equity
Securities
|
Other
Invested
Assets
|
Total
|
|||||||||||||
|
Gains
|
$
|
1,994
|
$
|
1,221
|
$
|
—
|
$
|
3,215
|
||||||||
|
Losses
|
(1,650
|
)
|
—
|
—
|
(1,650
|
)
|
||||||||||
|
Realized investment gains, net
|
$
|
344
|
$
|
1,221
|
$
|
—
|
$
|
1,565
|
||||||||
The following table presents the portion of unrealized gains (losses) related to equity securities still held for the three month and nine month periods ended September 30, 2020 and 2019.
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Net realized and unrealized gains (losses) recognized during the period on equity securities
|
$
|
(643
|
)
|
$
|
1,052
|
$
|
(7,743
|
)
|
$
|
3,317
|
||||||
|
Less: Net realized gains (losses) recognized during the period on equity securities sold during the period
|
88
|
108
|
88
|
1,221
|
||||||||||||
|
Unrealized gains (losses) recognized during the reporting period on equity securities, net
|
$
|
(731
|
)
|
$
|
944
|
$
|
(7,831
|
)
|
$
|
2,096
|
||||||
Variable Interest Entities
The Company holds passive interests in a number of entities that are considered to be variable interest entities (“VIEs”) under GAAP guidance. The Company’s VIE interests principally consist of
interests in limited partnerships and limited liability companies formed for the purpose of achieving diversified equity returns. The Company’s VIE interests, carried as a part of other invested assets, totaled $9,097 and $9,960 as of September 30,
2020 and December 31, 2019, respectively. The Company’s VIE interests, carried as a part of investment in unconsolidated trusts, totaled $1,238 as of September 30, 2020 and December 31, 2019.
The Company does not have power over the activities that most significantly impact the economic performance of these VIEs and thus is not the primary beneficiary. Therefore, the Company has not
consolidated these VIEs. The Company’s involvement with each VIE is limited to its direct ownership interest in the VIE. The Company has no arrangements with any of the VIEs to provide other financial support to or on behalf of the VIE. The Company’s
maximum loss exposure relative to these investments was limited to the carrying value of the Company’s investment in the VIEs, which amount to $10,335 and $11,198, as of September 30, 2020 and December 31, 2019, respectively. As of September 30, 2020
and December 31, 2019, the Company had outstanding commitments totaling $1,997, whereby the Company is committed to fund these investments and may be called by the partnership during the commitment period to fund the purchase of new investments and
partnership expenses.
| Note 4. |
Fair Values of Financial Instruments
|
The estimated fair values have been determined by the Company using available market information from various market sources and appropriate valuation methodologies as of the respective dates.
However, considerable judgment is necessary to interpret market data and to develop the estimates of fair value. Although management is not aware of any factors that would significantly affect the estimated fair value amounts, the estimates
presented herein are not necessarily indicative of the amounts which the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair
value amounts.
The following describes the fair value hierarchy and provides information as to the extent to which the Company uses fair value to measure the value of its financial instruments and information about
the inputs used to value those financial instruments. The fair value hierarchy prioritizes the inputs in the valuation techniques used to measure fair value into three broad levels.
| Level 1 |
Observable inputs that reflect quoted prices for identical assets or liabilities in active markets that the Company has the ability to access at the measurement date. The Company’s financial instruments valued using Level 1 criteria
include cash equivalents and exchange traded common stocks.
|
| Level 2 |
Observable inputs, other than quoted prices included in Level 1, for an asset or liability or prices for similar assets or liabilities. The Company’s financial instruments valued using Level 2 criteria include significantly most of its
fixed maturities, which consist of U.S. Treasury securities, U.S. Government securities, obligations of states and political subdivisions, and certain corporate fixed maturities, as well as its non-redeemable preferred stocks. In determining
fair value measurements of its fixed maturities and non-redeemable preferred stocks using Level 2 criteria, the Company utilizes data from outside sources, including nationally recognized pricing services and broker/dealers. Prices for the
majority of the Company’s Level 2 fixed maturities and non-redeemable preferred stocks were determined using unadjusted prices received from pricing services that utilize models where the significant inputs are observable (e.g. interest
rates, yield curves, prepayment speeds, default rates, loss severities) or can be corroborated by observable market data.
|
| Level 3 |
Valuations that are derived from techniques in which one or more of the significant inputs are unobservable (including assumptions about risk). Fair value is based on criteria that use assumptions or other data that are not readily
observable from objective sources. With little or no observable market, the determination of fair values uses considerable judgment and represents the Company’s best estimate of an amount that could be realized in a market exchange for the
asset or liability.
|
As of September 30, 2020, financial instruments carried at fair value were measured on a recurring basis as summarized below:
|
Quoted Prices
in Active
Markets
for Identical
Assets
(Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
|
|||||||||||||
|
Assets:
|
||||||||||||||||
|
Fixed maturities
|
$
|
—
|
$
|
247,997
|
$
|
—
|
$
|
247,997
|
||||||||
|
Equity securities
|
14,180
|
—
|
143
|
14,323
|
||||||||||||
|
Cash equivalents
|
7,769
|
—
|
—
|
7,769
|
||||||||||||
|
Total
|
$
|
21,949
|
$
|
247,997
|
$
|
143
|
$
|
270,089
|
||||||||
As of December 31, 2019, financial instruments carried at fair value were measured on a recurring basis as summarized below:
|
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
|
|||||||||||||
|
Assets:
|
||||||||||||||||
|
Fixed maturities
|
$
|
—
|
$
|
232,472
|
$
|
—
|
$
|
232,472
|
||||||||
|
Equity securities
|
22,922
|
—
|
—
|
22,922
|
||||||||||||
|
Cash equivalents
|
7,173
|
—
|
—
|
7,173
|
||||||||||||
|
Total
|
$
|
30,095
|
$
|
232,472
|
$
|
—
|
$
|
262,567
|
||||||||
The Company does not have any fixed maturities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) as of September 30, 2020 and December 31, 2019.
The following table sets forth the carrying amount, estimated fair value and level within the fair value hierarchy of the Company’s financial instruments as of September 30, 2020 and December 31,
2019.
|
September 30, 2020
|
December 31, 2019
|
|||||||||||||||||||
|
Level in Fair
Value
Hierarchy (1)
|
Carrying
Amount
|
Estimated
Fair Value
|
Carrying
Amount
|
Estimated
Fair Value
|
||||||||||||||||
|
Assets:
|
||||||||||||||||||||
|
Cash and cash equivalents
|
Level 1
|
$
|
8,940
|
$
|
8,940
|
$
|
12,893
|
$
|
12,893
|
|||||||||||
|
Fixed maturities
|
(1)
|
247,997
|
247,997
|
232,472
|
232,472
|
|||||||||||||||
|
Equity securities
|
(1)
|
14,323
|
14,323
|
22,922
|
22,922
|
|||||||||||||||
|
Other invested assets
|
Level 3
|
9,097
|
9,097
|
9,960
|
9,960
|
|||||||||||||||
|
Policy loans
|
Level 2
|
1,964
|
1,964
|
2,007
|
2,007
|
|||||||||||||||
|
Real estate
|
Level 2
|
38
|
38
|
38
|
38
|
|||||||||||||||
|
Investment in unconsolidated trusts
|
Level 2
|
1,238
|
1,238
|
1,238
|
1,238
|
|||||||||||||||
|
Liabilities:
|
||||||||||||||||||||
|
Junior subordinated debentures, net
|
Level 2
|
33,738
|
31,901
|
33,738
|
35,977
|
|||||||||||||||
| (1) |
See the aforementioned information for a description of the fair value hierarchy as well as a disclosure of levels for classes of these financial assets.
|
| Note 5. |
Liabilities for Unpaid Losses, Claims and Loss Adjustment Expenses
|
The roll-forward of liabilities for unpaid losses, claims and loss adjustment expenses for the nine months ended September 30, 2020 and 2019 is as follows:
|
Nine Months Ended
September 30,
|
||||||||
|
2020
|
2019
|
|||||||
|
Beginning liabilities for unpaid losses, claims and loss adjustment expenses, gross
|
$
|
81,448
|
$
|
72,612
|
||||
|
Less: Reinsurance recoverable on unpaid losses
|
(18,339
|
) |
(14,354
|
)
|
||||
|
Beginning liabilities for unpaid losses, claims and loss adjustment expenses, net
|
63,109
|
58,258
|
||||||
|
Incurred related to:
|
||||||||
|
Current accident year
|
91,788
|
103,017
|
||||||
|
Prior accident year development (1)
|
(2,740
|
)(2) |
(629
|
)
|
||||
|
Total incurred
|
89,048
|
102,388
|
||||||
|
Paid related to:
|
||||||||
|
Current accident year
|
57,676
|
66,682
|
||||||
|
Prior accident years
|
34,435
|
34,314
|
||||||
|
Total paid
|
92,111
|
100,996
|
||||||
|
Ending liabilities for unpaid losses, claims and loss adjustment expenses, net
|
60,046
|
59,650
|
||||||
|
Plus: Reinsurance recoverable on unpaid losses
|
18,111
|
16,611
|
||||||
|
Ending liabilities for unpaid losses, claims and loss adjustment expenses, gross
|
$
|
78,157
|
$
|
76,261
|
||||
| (1) |
In establishing property and casualty reserves, the Company initially reserves for losses at the higher end of the reasonable range if no other value within the range is determined to be more probable. Selection of such an initial loss
estimate is an attempt by management to give recognition that initial claims information received generally is not conclusive with respect to legal liability, is generally not comprehensive with respect to magnitude of loss and generally,
based on historical experience, will develop more adversely as time passes and more information becomes available. Accordingly, the Company generally experiences reserve redundancies when analyzing the development of prior year losses in a
current period.
|
| (2) |
Prior years’ development was primarily the result of favorable development in the loss and claim reserves for the Medicare supplement line of business in Bankers Fidelity. Rate increases on existing business and the resultant improvement
in rate adequacy was more favorable than expected.
|
Following is a reconciliation of total incurred losses to total insurance benefits and losses incurred:
|
Nine Months Ended
September 30,
|
||||||||
|
2020
|
2019
|
|||||||
|
Total incurred losses
|
$
|
89,048
|
$
|
102,388
|
||||
|
Cash surrender value and matured endowments
|
962
|
1,020
|
||||||
|
Benefit reserve changes
|
(132
|
)
|
769
|
|||||
|
Total insurance benefits and losses incurred
|
$
|
89,878
|
$
|
104,177
|
||||
| Note 6. |
Junior Subordinated Debentures
|
The Company has two unconsolidated Connecticut statutory business trusts, which exist for the exclusive purposes of: (i) issuing trust preferred securities (“Trust Preferred Securities”) representing
undivided beneficial interests in the assets of the trusts; (ii) investing the gross proceeds of the Trust Preferred Securities in junior subordinated deferrable interest debentures (“Junior Subordinated Debentures”) of Atlantic American; and (iii)
engaging in those activities necessary or incidental thereto.
The financial structure of each of Atlantic American Statutory Trust I and II as of September 30, 2020 was as follows:
|
Atlantic American
Statutory Trust I
|
Atlantic American
Statutory Trust II
|
||||||
|
JUNIOR SUBORDINATED DEBENTURES (1) (2)
|
|||||||
|
Principal amount owed September 30, 2020
|
$ |
18,042
|
$ |
23,196
|
|||
|
Less: Treasury debt (3)
|
—
|
(7,500
|
)
|
||||
|
Net balance September 30, 2020
|
$ |
18,042
|
$ |
15,696
|
|||
|
Net balance December 31, 2019
|
$ |
18,042
|
$ |
15,696
|
|||
|
Coupon rate
|
LIBOR + 4.00%
|
LIBOR + 4.10%
|
|||||
|
Interest payable
|
Quarterly
|
Quarterly
|
|||||
|
Maturity date
|
December 4, 2032
|
May 15, 2033
|
|||||
|
Redeemable by issuer
|
Yes
|
Yes
|
|||||
|
TRUST PREFERRED SECURITIES
|
|||||||
|
Issuance date
|
December 4, 2002
|
May 15, 2003
|
|||||
|
Securities issued
|
17,500
|
22,500
|
|||||
|
Liquidation preference per security
|
$ |
1
|
$ |
1
|
|||
|
Liquidation value
|
$ |
17,500
|
22,500
|
||||
|
Coupon rate
|
LIBOR + 4.00%
|
LIBOR + 4.10%
|
|||||
|
Distribution payable
|
Quarterly
|
Quarterly
|
|||||
|
Distribution guaranteed by (4)
|
Atlantic American Corporation
|
Atlantic American Corporation
|
|||||
| (1) |
For each of the respective debentures, the Company has the right at any time, and from time to time, to defer payments of interest on the Junior Subordinated Debentures for a period not exceeding 20 consecutive quarters up to the
debentures’ respective maturity dates. During any such period, interest will continue to accrue and the Company may not declare or pay any cash dividends or distributions on, or purchase, the Company’s common stock nor make any principal,
interest or premium payments on or repurchase any debt securities that rank equally with or junior to the Junior Subordinated Debentures. The Company has the right at any time to dissolve each of the trusts and cause the Junior Subordinated
Debentures to be distributed to the holders of the Trust Preferred Securities.
|
| (2) |
The Junior Subordinated Debentures are unsecured and rank junior and subordinate in right of payment to all senior debt of the Parent and are effectively subordinated to all existing and future liabilities of its subsidiaries.
|
| (3) |
On August 4, 2014, the Company acquired $7,500 of the Junior Subordinated Debentures.
|
| (4) |
The Parent has guaranteed, on a subordinated basis, all of the obligations under the Trust Preferred Securities, including payment of the redemption price and any accumulated and unpaid distributions to the extent of available funds and
upon dissolution, winding up or liquidation.
|
| Note 7. |
Earnings (Loss) Per Common Share
|
A reconciliation of the numerator and denominator used in the earnings (loss) per common share calculations is as follows:
|
Three Months Ended
September 30, 2020
|
||||||||||||
|
Income
|
Weighted
Average
Shares
(In thousands)
|
Per Share
Amount
|
||||||||||
|
Basic Earnings Per Common Share:
|
||||||||||||
|
Net income
|
$
|
1,876
|
20,438
|
|||||||||
|
Less preferred stock dividends
|
(100
|
)
|
—
|
|||||||||
|
Net income applicable to common shareholders
|
1,776
|
20,438
|
$
|
.09
|
||||||||
|
Diluted Earnings Per Common Share:
|
||||||||||||
|
Effect of Series D preferred stock
|
100
|
1,378
|
||||||||||
|
Net income applicable to common shareholders
|
$
|
1,876
|
21,816
|
$
|
.09
|
|||||||
|
Three Months Ended
September 30, 2019
|
||||||||||
|
Loss
|
Weighted
Average
Shares
(In thousands)
|
Per Share
Amount
|
||||||||
|
Basic and Diluted Loss Per Common Share:
|
||||||||||
|
Net loss
|
$
|
(1,392
|
)
|
20,250
|
||||||
|
Less preferred stock dividends
|
(100
|
)
|
—
|
|||||||
|
Net loss applicable to common shareholders
|
$
|
(1,492
|
)
|
20,250
|
$ |
(.07)
|
||||
|
Nine Months Ended
September 30, 2020
|
||||||||||
|
Income
|
Weighted
Average
Shares
(In thousands)
|
Per Share
Amount
|
||||||||
|
Basic and Diluted Income Per Common Share:
|
||||||||||
|
Net income
|
$
|
321
|
20,450
|
|||||||
|
Less preferred stock dividends
|
(299
|
)
|
—
|
|||||||
|
Net income applicable to common shareholders
|
$
|
22
|
20,450
|
$ |
—
|
|||||
|
Nine Months Ended
September 30, 2019
|
||||||||||
|
Loss
|
Weighted
Average
Shares
(In thousands)
|
Per Share
Amount
|
||||||||
|
Basic and Diluted Loss Per Common Share:
|
||||||||||
|
Net loss
|
$
|
(1,656
|
)
|
20,185
|
||||||
|
Less preferred stock dividends
|
(299
|
)
|
—
|
|||||||
|
Net loss applicable to common shareholders
|
$
|
(1,955
|
)
|
20,185
|
$ |
(.10)
|
||||
The assumed conversion of the Company’s Series D preferred stock was excluded from the earnings (loss) per common share calculation for all periods presented, except for the three month period ended
September 30, 2020, since its impact would have been antidilutive.
| Note 8. |
Income Taxes
|
A reconciliation of the differences between income taxes computed at the federal statutory income tax rate and income tax expense (benefit) is as follows:
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Federal income tax provision at statutory rate of 21%
|
$
|
511
|
$
|
(366
|
)
|
$
|
102
|
$
|
(430
|
)
|
||||||
|
Dividends-received deduction
|
(3
|
)
|
(6
|
)
|
(9
|
)
|
(20
|
)
|
||||||||
|
Other permanent differences
|
31
|
41
|
55
|
79
|
||||||||||||
|
Adjustment for prior years’ estimates to actual
|
18
|
(21
|
)
|
18
|
(21
|
)
|
||||||||||
|
Income tax expense (benefit)
|
$
|
557
|
$
|
(352
|
)
|
$
|
166
|
$
|
(392
|
)
|
||||||
The components of income tax benefit were:
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Current – Federal
|
$
|
705
|
$
|
(368
|
)
|
$
|
3,007
|
$
|
204
|
|||||||
|
Deferred – Federal
|
(148
|
)
|
16
|
(2,841
|
)
|
(596
|
)
|
|||||||||
|
Total
|
$
|
557
|
$
|
(352
|
)
|
$
|
166
|
$
|
(392
|
)
|
||||||
In addition, the Company determined there were no significant tax implications as a result of the CARES Act.
| Note 9. |
Leases
|
The Company has identified two operating lease agreements, each for the use of office space in the ordinary course of business.
The first lease renews annually on an automatic basis and based on original assumptions, management is reasonably certain to exercise the renewal option for an additional eight years from the January
1, 2019 effective date of the new lease guidance. The original term of the second lease was ten years and amended in January 2017 to provide for an additional seven years, with a termination date on September 30, 2026. The rate used in determining
the present value of lease payments is based upon an estimate of the Company’s incremental secured borrowing rate commensurate with the term of the underlying lease.
These leases are accounted for as operating leases, whereby lease expense is recognized on a straight-line basis over the term of the lease. Lease expense reported for the nine months ended September
30, 2020 and September 30, 2019 was $507.
Additional information regarding the Company’s real estate operating leases is as follows:
|
Nine Months Ended
September 30,
|
||||||||
|
Other information on operating leases:
|
2020
|
2019
|
||||||
|
Cash payments included in the measurement of lease liabilities reported in operating cash flows
|
$
|
726
|
$
|
632
|
||||
|
Right-of-use assets included in other assets on the condensed consolidated balance sheet
|
4,997
|
5,631
|
||||||
|
Weighted average discount rate
|
6.8
|
%
|
6.8
|
%
|
||||
|
Weighted average remaining lease term in years
|
6.1 years
|
7.1 years
|
||||||
The following table presents maturities and present value of the Company’s lease liabilities:
|
Lease Liability
|
||||
|
Remainder of 2020
|
$
|
251
|
||
|
2021
|
1,015
|
|||
|
2022
|
1,031
|
|||
|
2023
|
1,048
|
|||
|
2024
|
1,065
|
|||
|
Thereafter
|
2,025
|
|||
|
Total undiscounted lease payments
|
6,435
|
|||
|
Less: present value adjustment
|
1,204
|
|||
|
Operating lease liability included in accounts payable and accrued expenses on the condensed consolidated balance sheet
|
$
|
5,231
|
||
As of September 30, 2020, the Company has no operating leases that have not yet commenced.
| Note 10. |
Commitments and Contingencies
|
From time to time, the Company is, and expects to continue to be, involved in various claims and lawsuits incidental to and in the ordinary course of its businesses. In the opinion of management, any
such known claims are not expected to have a material effect on the financial condition or results of operations of the Company.
| Note 11. |
Segment Information
|
The Parent’s primary insurance subsidiaries, American Southern and Bankers Fidelity, operate in two principal business units, each focusing on specific products. American Southern operates in the
property and casualty insurance market, while Bankers Fidelity operates in the life and health insurance market. Each business unit is managed independently and is evaluated on its individual performance. The following sets forth the assets, revenue
and income (loss) before income taxes for each business unit as of and for the periods ended 2020 and 2019.
|
Assets
|
September 30,
2020
|
December 31,
2019
|
||||||
|
American Southern
|
$
|
151,865
|
$
|
141,524
|
||||
|
Bankers Fidelity
|
221,982
|
224,122
|
||||||
|
Corporate and Other
|
11,105
|
11,980
|
||||||
|
Total assets
|
$
|
384,952
|
$
|
377,626
|
||||
|
Revenues
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
American Southern
|
$
|
15,649
|
$
|
14,605
|
$
|
47,772
|
$
|
45,580
|
||||||||
|
Bankers Fidelity
|
30,875
|
32,311
|
88,619
|
97,931
|
||||||||||||
|
Corporate and Other
|
(255
|
)
|
829
|
(975
|
)
|
2,379
|
||||||||||
|
Total revenue
|
$
|
46,269
|
$
|
47,745
|
$
|
135,416
|
$
|
145,890
|
||||||||
|
Income (Loss) Before Income Taxes
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
American Southern
|
$
|
1,857
|
$
|
471
|
$
|
4,822
|
$
|
3,849
|
||||||||
|
Bankers Fidelity
|
2,765
|
(1,334
|
)
|
2,023
|
(3,828
|
)
|
||||||||||
|
Corporate and Other
|
(2,189
|
)
|
(881
|
)
|
(6,358
|
)
|
(2,069
|
)
|
||||||||
|
Income (loss) before income taxes
|
$
|
2,433
|
$
|
(1,744
|
)
|
$
|
487
|
$
|
(2,048
|
)
|
||||||
| Note 12. |
Related Party Transactions
|
During the nine month period ended September 30, 2019, the Company transferred its remaining fractional interest in an aircraft arrangement to Gray Television, Inc., a related party, for $151.
| Note 13. |
Subsequent Events
|
Since September 30, 2020, the COVID-19 pandemic continues to cause material disruption to financial markets and the economy. As a result of the pandemic, the Company could experience future losses
in its investment portfolio as a result of the weakened and volatile markets. Additionally, the Company can experience increased risk of loss any time unforeseen infectious diseases impact large portions of a population. Specifically, the Company’s
life and health business could experience significant loss due to increased claims volume arising from COVID-19. The duration and impact of the COVID-19 pandemic is unknown at this time and it is not possible to reliably estimate the impact on the
financial condition, operating results or liquidity of the Company and its operating subsidiaries in future periods.
Item 2.
AND RESULTS OF OPERATIONS
Overview
The following is management’s discussion and analysis of the financial condition and results of operations of Atlantic American Corporation (“Atlantic American” or the “Parent”) and its subsidiaries
(collectively with the Parent, the “Company”) as of and for the three month and nine month periods ended September 30, 2020. This discussion should be read in conjunction with the unaudited condensed consolidated financial statements and notes
thereto included elsewhere herein, as well as with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 (the “2019 Annual Report”).
Atlantic American is an insurance holding company whose operations are conducted primarily through its insurance subsidiaries: American Southern Insurance Company and American Safety Insurance
Company (together known as “American Southern”) and Bankers Fidelity Life Insurance Company and Bankers Fidelity Assurance Company (together known as “Bankers Fidelity”). Each operating company is managed separately, offers different products and is
evaluated on its individual performance.
Recent Events and Outlook
On March 11, 2020, the World Health Organization designated COVID-19 as a global pandemic. In March 2020, the impact of COVID-19 and related actions to attempt to control its spread began to impact
our business operations, and we expect that the pandemic, actions that have been or will be taken in response to it and its overall impact on the economy, will continue to have an effect on our business operations and our operating results. See
“Expected Impact of COVID-19 on the Company’s Financial Condition and Results of Operations.”
Critical Accounting Policies
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that
affect reported amounts and related disclosures. Actual results could differ significantly from those estimates. The Company has identified certain estimates that involve a higher degree of judgment and are subject to a significant degree of
variability. The Company’s critical accounting policies and the resultant estimates considered most significant by management are disclosed in the 2019 Annual Report. Except as disclosed in Note 2 of Notes to Condensed Consolidated Financial
Statements, the Company’s critical accounting policies are consistent with those disclosed in the 2019 Annual Report.
Overall Corporate Results
The following presents the Company’s revenue, expenses and net income (loss) for the three month and nine month periods ended September 30, 2020 and the comparable period in 2019:
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Insurance premiums, net
|
$
|
44,978
|
$
|
45,005
|
$
|
137,027
|
$
|
135,256
|
||||||||
|
Net investment income
|
1,828
|
2,187
|
5,717
|
6,834
|
||||||||||||
|
Realized investment gains (losses), net
|
183
|
(430
|
)
|
432
|
1,565
|
|||||||||||
|
Unrealized gains (losses) on equity securities, net
|
(731
|
)
|
944
|
(7,831
|
)
|
2,096
|
||||||||||
|
Other income
|
11
|
39
|
71
|
139
|
||||||||||||
|
Total revenue
|
46,269
|
47,745
|
135,416
|
145,890
|
||||||||||||
|
Insurance benefits and losses incurred
|
29,219
|
34,719
|
89,878
|
104,177
|
||||||||||||
|
Commissions and underwriting expenses
|
11,202
|
11,471
|
34,682
|
33,995
|
||||||||||||
|
Interest expense
|
363
|
533
|
1,253
|
1,624
|
||||||||||||
|
Other expense
|
3,052
|
2,766
|
9,116
|
8,142
|
||||||||||||
|
Total benefits and expenses
|
43,836
|
49,489
|
134,929
|
147,938
|
||||||||||||
|
Income (loss) before income taxes
|
$
|
2,433
|
$
|
(1,744
|
)
|
$
|
487
|
$
|
(2,048
|
)
|
||||||
|
Net income (loss)
|
$
|
1,876
|
$
|
(1,392
|
)
|
$
|
321
|
$
|
(1,656
|
)
|
||||||
Management also considers and evaluates performance by analyzing the non-GAAP measure operating income (loss), and believes it is a useful metric for investors, potential investors, securities
analysts and others because it isolates the “core” operating results of the Company before considering certain items that are either beyond the control of management (such as taxes, which are subject to timing, regulatory and rate changes depending
on the timing of the associated revenues and expenses) or are not expected to regularly impact the Company’s operational results (such as any realized and unrealized investment gains, which are not a part of the Company’s primary operations and are,
to a limited extent, subject to discretion in terms of timing of realization).
A reconciliation of net income (loss) to operating income (loss) for the three month and nine month periods ended September 30, 2020 and the comparable period in 2019 is as follows:
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
Reconciliation of Non-GAAP Financial Measure
|
2020
|
2019
|
2020
|
2019
|
||||||||||||
|
(In thousands)
|
||||||||||||||||
|
Net income (loss)
|
$
|
1,876
|
$
|
(1,392
|
)
|
$
|
321
|
$
|
(1,656
|
)
|
||||||
|
Income tax expense (benefit)
|
557
|
(352
|
)
|
166
|
(392
|
)
|
||||||||||
|
Realized investment (gains) losses, net
|
(183
|
)
|
430
|
(432
|
)
|
(1,565
|
)
|
|||||||||
|
Unrealized (gains) losses on equity securities, net
|
731
|
(944
|
)
|
7,831
|
(2,096
|
)
|
||||||||||
|
Non-GAAP operating income (loss)
|
$
|
2,981
|
$
|
(2,258
|
)
|
$
|
7,886
|
$
|
(5,709
|
)
|
||||||
On a consolidated basis, the Company had net income of $1.9 million, or $0.09 per diluted share, for the three month period ended September 30, 2020, compared to net loss of $1.4 million, or $0.07
per diluted share, for the three month period ended September 30, 2019. The Company had net income of $0.3 million, or $0.00 per diluted share, for the nine month period ended September 30, 2020, compared to net loss of $1.7 million, or $0.10 per
diluted share, for the nine month period ended September 30, 2019.
Operating income increased $5.2 million in the three month period ended September 30, 2020 from the three month period ended September 30, 2019. For the nine month period ended September 30, 2020,
operating income increased $13.6 million over the comparable period in 2019. The increase in operating income was primarily due to favorable loss experience in the life and health operations, resulting from a significant decrease in the number of
incurred claims within the Medicare supplement line of business. This decrease in the number of incurred claims was primarily attributable to the Company’s individual policy holders being subject to varying degrees of shelter in place orders
instituted throughout the United States during 2020 as a result of COVID-19. For the three month period ended September 30, 2020, premium decreased slightly from the comparable period in 2019. For the nine month period ended September 30, 2020,
premium revenue increased $1.8 million, or 1.3%, to $137.0 million from $135.3 million in the comparable period in 2019. The increase in premium revenue was primarily attributable to an increase in the automobile physical damage line of business in
the property and casualty operations.
A more detailed analysis of the individual operating segments and other corporate activities follows.
American Southern
The following summarizes American Southern’s premiums, losses, expenses and underwriting ratios for the three month and nine month periods ended September 30, 2020 and the comparable periods in 2019:
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
(Dollars in thousands)
|
||||||||||||||||
|
Gross written premiums
|
$
|
11,574
|
$
|
9,953
|
$
|
54,512
|
$
|
50,228
|
||||||||
|
Ceded premiums
|
(1,519
|
)
|
(1,403
|
)
|
(4,364
|
)
|
(4,091
|
)
|
||||||||
|
Net written premiums
|
$
|
10,055
|
$
|
8,550
|
$
|
50,148
|
$
|
46,137
|
||||||||
|
Net earned premiums
|
$
|
14,770
|
$
|
14,475
|
$
|
45,516
|
$
|
43,035
|
||||||||
|
Insurance benefits and losses incurred
|
9,131
|
9,440
|
28,686
|
28,346
|
||||||||||||
|
Commissions and underwriting expenses
|
4,662
|
4,696
|
14,264
|
13,386
|
||||||||||||
|
Underwriting income
|
$
|
977
|
$
|
339
|
$
|
2,566
|
$
|
1,303
|
||||||||
|
Loss ratio
|
61.8
|
%
|
65.2
|
%
|
63.0
|
%
|
65.9
|
%
|
||||||||
|
Expense ratio
|
31.6
|
32.4
|
31.3
|
31.1
|
||||||||||||
|
Combined ratio
|
93.4
|
%
|
97.6
|
%
|
94.3
|
%
|
97.0
|
%
|
||||||||
Gross written premiums at American Southern increased $1.6 million, or 16.3%, during the three month period ended September 30, 2020 and $4.3 million, or 8.5%, during the nine month period ended
September 30, 2020, from the comparable periods in 2019. The increase in gross written premiums was primarily attributable to an increase in premiums written in the automobile physical damage line of business due to a new agency that started in the
second half of 2019, as well as increased writings from certain existing agencies.
Ceded premiums increased $0.1 million, or 8.3%, during the three month period ended September 30, 2020 and $0.3 million, or 6.7%, during the nine month period ended September 30, 2020, from the
comparable periods in 2019. American Southern’s ceded premiums are typically determined as a percentage of earned premiums and generally increase or decrease as earned premiums increase or decrease. Also contributing to the increase in ceded
premiums in 2020 was an increase in earned premiums in certain accounts within the automobile physical damage and general liability lines of business, which are subject to reinsurance.
The following presents American Southern’s net earned premiums by line of business for the three month and nine month periods ended September 30, 2020 and the comparable periods in 2019:
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
(In thousands)
|
||||||||||||||||
|
Automobile liability
|
$
|
6,804
|
$
|
7,585
|
$
|
22,167
|
$
|
22,422
|
||||||||
|
Automobile physical damage
|
4,499
|
3,597
|
13,519
|
10,998
|
||||||||||||
|
General liability
|
1,008
|
884
|
2,747
|
2,487
|
||||||||||||
|
Surety
|
1,417
|
1,552
|
4,463
|
4,847
|
||||||||||||
|
Other lines
|
1,042
|
857
|
2,620
|
2,281
|
||||||||||||
|
Total
|
$
|
14,770
|
$
|
14,475
|
$
|
45,516
|
$
|
43,035
|
||||||||
Net earned premiums increased $0.3 million, or 2.0%, during the three month period ended September 30, 2020, and increased $2.5 million, or 5.8%, during the nine month period ended September 30,
2020, over the comparable periods in 2019. The increase in net earned premiums was primarily attributable to an increase in automobile physical damage coverage resulting from the new agency as previously mentioned. Premiums are earned ratably over
their respective policy terms, and therefore premiums earned in the current year are related to policies written during both the current year and immediately preceding year.
The performance of an insurance company is often measured by its combined ratio. The combined ratio represents the percentage of losses, loss adjustment expenses and other expenses that are incurred
for each dollar of premium earned by the company. A combined ratio of under 100% represents an underwriting profit while a combined ratio of over 100% indicates an underwriting loss. The combined ratio is divided into two components, the loss ratio
(the ratio of losses and loss adjustment expenses incurred to premiums earned) and the expense ratio (the ratio of expenses incurred to premiums earned).
Insurance benefits and losses incurred at American Southern decreased $0.3 million, or 3.3%, during the three month period ended September 30, 2020, and increased $0.3 million, or 1.2%, during the
nine month period ended September 30, 2020, over the comparable periods in 2019. As a percentage of earned premiums, net loss and loss adjustment expenses were 61.8% in the three month period ended September 30, 2020, compared to 65.2% in the three
month period ended September 30, 2019. For the nine month period ended September 30, 2020, this ratio decreased to 63.0% from 65.9% in the comparable period in 2019. The decrease in the loss ratio during the three month period and nine month periods
ended September 30, 2020 was primarily due to a decrease in the severity of claims in the automobile liability line of business. Partially offsetting the decrease in the loss ratio during the three month and nine month periods ended September 30,
2020 was less favorable loss experience in the automobile physical damage line of business due to an increase in frequency of claims from the new agency.
Commissions and underwriting expenses decreased slightly during the three month period ended September 30, 2020, and increased $0.9 million, or 6.6%, during the nine month period ended September 30,
2020, over the comparable periods in 2019. As a percentage of earned premiums, underwriting expenses were 31.6% in the three month period ended September 30, 2020, compared to 32.4% in the three month period ended September 30, 2019. For the nine
month period ended September 30, 2020, this ratio increased to 31.3% from 31.1% in the comparable period in 2019. The decrease in the expense ratio during the three month period ended September 30, 2020 was primarily attributable to an increase in
earned premiums coupled with a slight decrease in commissions and underwriting expenses. The increase in the expense ratio during the nine month period ended September 30, 2020 was primarily due to American Southern’s use of a variable commission
structure with certain agents, which compensates the participating agents in relation to the loss ratios of the business they write. During periods in which the loss ratio decreases, commissions and underwriting expenses will generally increase, and
conversely, during periods in which the loss ratio increases, commissions and underwriting expenses will generally decrease.
Bankers Fidelity
The following summarizes Bankers Fidelity’s earned premiums, losses, expenses and underwriting ratios for the three month and nine month periods ended September 30, 2020 and the comparable periods in
2019:
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
(Dollars in thousands)
|
||||||||||||||||
|
Medicare supplement
|
$
|
43,573
|
$
|
44,810
|
$
|
131,675
|
$
|
133,680
|
||||||||
|
Other health products
|
2,385
|
1,953
|
6,880
|
5,839
|
||||||||||||
|
Life insurance
|
2,256
|
2,075
|
7,070
|
6,371
|
||||||||||||
|
Gross earned premiums
|
48,214
|
48,838
|
145,625
|
145,890
|
||||||||||||
|
Ceded premiums
|
(18,006
|
)
|
(18,308
|
)
|
(54,114
|
)
|
(53,669
|
)
|
||||||||
|
Net earned premiums
|
30,208
|
30,530
|
91,511
|
92,221
|
||||||||||||
|
Insurance benefits and losses incurred
|
20,088
|
25,279
|
61,192
|
75,831
|
||||||||||||
|
Commissions and underwriting expenses
|
8,021
|
8,365
|
25,403
|
25,927
|
||||||||||||
|
Total expenses
|
28,109
|
33,644
|
86,595
|
101,758
|
||||||||||||
|
Underwriting income (loss)
|
$
|
2,099
|
$
|
(3,114
|
)
|
$
|
4,916
|
$
|
(9,537
|
)
|
||||||
|
Loss ratio
|
66.5
|
%
|
82.8
|
%
|
66.9
|
%
|
82.2
|
%
|
||||||||
|
Expense ratio
|
26.6
|
27.4
|
27.8
|
28.1
|
||||||||||||
|
Combined ratio
|
93.1
|
%
|
110.2
|
%
|
94.7
|
%
|
110.3
|
%
|
||||||||
Net earned premium revenue at Bankers Fidelity decreased $0.3 million, or 1.1%, during the three month period ended September 30, 2020, and $0.7 million, or 0.8%, during the nine month period ended
September 30, 2020, from the comparable periods in 2019. Gross earned premiums from the Medicare supplement line of business decreased $1.2 million, or 2.8%, during the three month period ended September 30, 2020, and $2.0 million, or 1.5%, during
the nine month period ended September 30, 2020, due primarily to non-renewals exceeding the level of new business writings. Other health product premiums increased $0.4 million, or 22.1%, during the three month period ended September 30, 2020, and
$1.0 million, or 17.8%, during the nine month period ended September 30, 2020, over the comparable periods in 2019, primarily as a result of new sales of the company’s group health products. Gross earned premiums from the life insurance line of
business increased $0.2 million, or 8.7%, during the three month period ended September 30, 2020, and $0.7 million, or 11.0%, during the nine month period ended September 30, 2020 over the comparable periods in 2019 due to an increase in the group
life products premium. Partially offsetting the increase in gross earned premiums from the life insurance line was a decrease in individual life products premium, resulting from the redemption and settlement of existing individual life policy
obligations exceeding the level of new individual life sales. Premiums ceded decreased $0.3 million, or 1.6%, during the three month period ended September 30, 2020 and increased $0.4 million, or 0.8%, during the nine month period ended September
30, 2020, over the comparable periods in 2019. The decrease in ceded premiums for the three month period ended September 30, 2020 was due to non-renewals exceeding the level of new business writings, as previously discussed. The increase in ceded
premiums for the nine month period ended September 30, 2020 was due to an increase in Medicare supplement premiums subject to reinsurance.
Insurance benefits and losses incurred decreased $5.2 million, or 20.5%, during the three month period ended September 30, 2020, and $14.6 million, or 19.3%, during the nine month period ended
September 30, 2020, from the comparable periods in 2019. As a percentage of earned premiums, benefits and losses were 66.5% in the three month period ended September 30, 2020, compared to 82.8% in the three month period ended September 30, 2019.
For the nine month period ended September 30, 2020, this ratio decreased to 66.9% from 82.2% in the comparable period in 2019. The decrease in the loss ratio for the three month and nine month periods ended September 30, 2020 was primarily due to a
significantly lower number of claims incurred in the Medicare supplement line of business due to the Company’s individual policy holders being subject to varying degrees of shelter in place orders instituted throughout the United States during 2020
as a result of COVID-19. Also contributing to the decrease in the loss ratio was an improvement in rate adequacy in the Medicare supplement line of business as a result of implementation of rate increases on existing business.
Commissions and underwriting expenses decreased $0.3 million, or 4.1%, during the three month period ended September 30, 2020, and $0.5 million, or 2.0%, during the nine month period ended September
30, 2020, over the comparable periods in 2019. As a percentage of earned premiums, underwriting expenses were 26.6% in the three month period ended September 30, 2020, compared to 27.4% in the three month period ended September 30, 2019. For the
nine month period ended September 30, 2020, this ratio decreased to 27.8% from 28.1% in the comparable period in 2019. The decrease in the expense ratio for the three month and nine month periods ended September 30, 2020 was primarily due to a
decrease in agent incentive costs and realization of costs saving initiatives, predominantly related to postage costs.
Net Investment Income and Realized Gains (Losses)
Investment income decreased $0.4 million, or 16.4%, during the three month period ended September 30, 2020, and $1.1 million, or 16.3%, during the nine month period ended September 30, 2020, over the
comparable periods in 2019. The decrease in investment income was primarily attributable to net losses in the Company’s other invested assets.
The Company had net realized investment gains of $0.2 million during the three month period ended September 30, 2020, compared to net realized investment losses of $0.4 million during the three month
period ended September 30, 2019. The Company had net realized investment gains of $0.4 million during the nine month period ended September 30, 2020, compared to net realized investment gains of $1.6 million during the nine month period ended
September 30, 2019. The net realized investment gains during the three month and nine month periods ended September 30, 2020 resulted primarily from the disposition of several of the Company’s investments in fixed maturity securities. Management
continually evaluates the Company’s investment portfolio and makes adjustments for impairments and/or divests investments as may be determined to be appropriate.
Unrealized Gains (Losses) on Equity Securities
Investments in equity securities are measured at fair value at the end of the reporting period, with any changes in fair value reported in net income during the period, with certain exceptions. The
Company recognized net unrealized losses on equity securities of $0.7 million during the three month period ended September 30, 2020 and unrealized gains on equity securities of $0.9 million during the three month period ended September 30, 2019.
The Company recognized net unrealized losses on equity securities of $7.8 million during the nine month period ended September 30, 2020 and unrealized gains on equity securities of $2.1 million during the nine month period ended September 30, 2019.
Changes in unrealized gains on equity securities for the applicable periods are primarily the result of fluctuations in the market value of certain of the Company’s equity securities.
Interest Expense
Interest expense decreased $0.2 million, or 31.9%, during the three month period ended September 30, 2020, and $0.4 million, or 22.8%, during the nine month period ended September 30, 2020, from the
comparable periods in 2019. Changes in interest expense were primarily due to a decline in the London Interbank Offered Rate (“LIBOR”), as the interest rates on the Company’s outstanding junior subordinated deferrable interest debentures (“Junior
Subordinated Debentures”) are directly related to LIBOR.
Liquidity and Capital Resources
The primary cash needs of the Company are for the payment of claims and operating expenses, maintaining adequate statutory capital and surplus levels, and meeting debt service requirements. Current
and expected patterns of claim frequency and severity may change from period to period but generally are expected to continue within historical ranges. The Company’s primary sources of cash are written premiums, investment income and proceeds from
the sale and maturity of its invested assets. The Company believes that, within each operating company, total invested assets will be sufficient to satisfy all policy liabilities and that cash inflows from investment earnings, future premium receipts
and reinsurance collections will be adequate to fund the payment of claims and operating expenses as needed.
Cash flows at the Parent are derived from dividends, management fees, and tax-sharing payments, as described below, from the subsidiaries. The principal cash needs of the Parent are for the payment
of operating expenses, the acquisition of capital assets and debt service requirements, as well as the repurchase of shares and payments of any dividends as may be authorized and approved by the Company’s board of directors from time to time. At
September 30, 2020, the Parent had approximately $4.6 million of unrestricted cash and investments.
The Parent’s insurance subsidiaries reported statutory net income of $8.5 million for the nine month period ended September 30, 2020, compared to statutory net loss of $4.2 million for the nine month
period ended September 30, 2019. Statutory results are impacted by the recognition of all costs of acquiring business. In periods in which the Company’s first year premiums increase, statutory results are generally lower than results determined under
GAAP. Statutory results for the Company’s property and casualty operations may differ from the Company’s results of operations under GAAP due to the deferral of acquisition costs for financial reporting purposes. The Company’s life and health
operations’ statutory results may differ from GAAP results primarily due to the deferral of acquisition costs for financial reporting purposes, as well as the use of different reserving methods.
Over 90% of the invested assets of the Parent’s insurance subsidiaries are invested in marketable securities that can be converted into cash, if required; however, the use of such assets by the
Company is limited by state insurance regulations. Dividend payments to a parent corporation by its wholly owned insurance subsidiaries are subject to annual limitations and are restricted to 10% of statutory surplus or statutory earnings before
recognizing realized investment gains of the individual insurance subsidiaries. At September 30, 2020, American Southern had $46.4 million of statutory capital and surplus and Bankers Fidelity had $35.7 million of statutory capital and surplus. In
2020, dividend payments by the Parent’s insurance subsidiaries in excess of $4.6 million would require prior approval. Through September 30, 2020, the Parent received dividends of $2.7 million from its subsidiaries.
The Parent provides certain administrative and other services to each of its insurance subsidiaries. The amounts charged to and paid by the subsidiaries include reimbursements for various shared
services and other expenses incurred directly on behalf of the subsidiaries by the Parent. In addition, there is in place a formal tax-sharing agreement between the Parent and its insurance subsidiaries. As a result of the Parent’s tax loss, it is
anticipated that the tax-sharing agreement will continue to provide the Parent with additional funds from profitable subsidiaries to assist in meeting its cash flow obligations.
The Company has two statutory trusts which exist for the exclusive purpose of issuing trust preferred securities representing undivided beneficial interests in the assets of the trusts and investing
the gross proceeds of the trust preferred securities in Junior Subordinated Debentures. The outstanding $18.0 million and $15.7 million of Junior Subordinated Debentures mature on December 4, 2032 and May 15, 2033, respectively, are callable
quarterly, in whole or in part, only at the option of the Company, and have an interest rate of three-month LIBOR plus an applicable margin. The margin ranges from 4.00% to 4.10%. At September 30, 2020, the effective interest rate was 4.32%. The
obligations of the Company with respect to the issuances of the trust preferred securities represent a full and unconditional guarantee by the Parent of each trust’s obligations with respect to the trust preferred securities. Subject to certain
exceptions and limitations, the Company may elect from time to time to defer Junior Subordinated Debenture interest payments, which would result in a deferral of distribution payments on the related trust preferred securities. As of September 30,
2020, the Company has not made such an election.
The Company intends to pay its obligations under the Junior Subordinated Debentures using existing cash balances, dividend and tax-sharing payments from the operating subsidiaries, or from potential
future financing arrangements.
At September 30, 2020, the Company had 55,000 shares of Series D preferred stock (“Series D Preferred Stock”) outstanding. All of the shares of Series D Preferred Stock are held by an affiliate of
the Company’s controlling shareholder. The outstanding shares of Series D Preferred Stock have a stated value of $100 per share; accrue annual dividends at a rate of $7.25 per share (payable in cash or shares of the Company’s common stock at the
option of the board of directors of the Company) and are cumulative. In certain circumstances, the shares of the Series D Preferred Stock may be convertible into an aggregate of approximately 1,378,000 shares of the Company’s common stock, subject to
certain adjustments and provided that such adjustments do not result in the Company issuing more than approximately 2,703,000 shares of common stock without obtaining prior shareholder approval; and are redeemable solely at the Company’s option. The
Series D Preferred Stock is not currently convertible. At September 30, 2020, the Company had accrued but unpaid dividends on the Series D Preferred Stock totaling $0.3 million.
During 2020, Bankers Fidelity Life Insurance Company (“BFLIC”) became a member of the Federal Home Loan Bank of Atlanta (“FHLB”), for the primary purpose of enhancing financial flexibility. As a member, BFLIC can
obtain access to low-cost funding and also receive dividends on FHLB stock. The membership arrangement established initial credit availability of five percent of statutory admitted assets, or approximately $8 million. Additional FHLB stock
purchases may be required based upon the amount of funds borrowed from the FHLB. BFLIC would be required to post acceptable forms of collateral for any borrowings it makes from the FHLB. To date, BFLIC has not made any borrowings from the FHLB.
Cash and cash equivalents decreased from $12.9 million at December 31, 2019 to $8.9 million at September 30, 2020. The decrease in cash and cash equivalents during the nine month period ended
September 30, 2020 was primarily attributable to a $2.8 million decrease resulting from purchases of securities exceeding investment sales and maturity of securities in addition to net cash used in operating activities of $0.9 million.
The Company believes that existing cash balances as well as the dividends, fees, and tax-sharing payments it expects to receive from its subsidiaries and, if needed, additional borrowings from
financial institutions, will enable the Company to meet its liquidity requirements for the foreseeable future. Management is not aware of any current recommendations by regulatory authorities, which, if implemented, would have a material adverse
effect on the Company’s liquidity, capital resources or operations.
Expected Impact of COVID-19 on the Company’s Financial Condition and Results of Operations
The duration and impact of the COVID-19 pandemic is unknown at this time and it is not possible for us to reliably estimate the impact on the financial condition, operating results or liquidity of
the Company and its operating subsidiaries in future periods. However, we do not currently expect a significant decline in liquidity or operating results as a result of the disruption caused by the ongoing COVID-19 pandemic. To date, the most
significant impact of COVID-19 on the Company’s financial position has been volatility in the fair value of the Company’s fixed maturity and equity investments due to disruption in the financial markets.
We expect that earned premiums could be adversely impacted by a weakened economy leading to a slowdown in new sales and reduced retention of insureds. Additionally, a number of states have issued
bulletins that either encourage or require premium leniency such as extension of grace periods or moratoriums on cancellation of policies for non-payment. The Company does not expect a significant reduction or delay in payments and continues to
monitor state required actions as they develop.
For the Company’s property and casualty operations, the majority of premium revenue is derived from automobile liability and automobile physical damage lines of business written on a multi-year
contract basis with state and local governments. Although we cannot predict with certainty at this time, we do not expect a significant level of cancellations or non-renewals of our property and casualty contracts in the short term but recognize
that a prolonged economic slowdown could adversely affect future results. However, it is expected that certain automobile programs may request partial premium refunds as a result of a decline in usage, which the Company will continue to evaluate.
Benefits and losses in our property and casualty operations could be adversely impacted as a result of disruption caused by the COVID-19 pandemic. However, due to the nature of our primary product
lines, the impact is not currently expected to be material. Additionally, we expect to see a reduction in frequency and severity of claims in the automobile lines of business as fewer miles are driven and less people are on the roads. As a result,
we do not currently expect a material adverse effect on operating results or liquidity in the property and casualty operations.
The majority of premium revenue in our life and health operations are derived from the senior market segment of the population, or those individuals age sixty-five and up, who maintain Medicare
supplement and to a lesser extent, whole life insurance policies with the Company. We expect that earned premiums could be adversely impacted by the rise in unemployment and economic slowdown related to the COVID-19 pandemic and individual, business
and government responses thereto, which could lead to a decline in new sales and reduced retention of insureds. As a result, we currently anticipate that the life and health operations may experience a marginal decline in earned premiums although
the actual impact cannot be predicted with certainty at this time.
Unforeseen infectious diseases that impact large portions of a population can have an adverse impact on mortality and morbidity, and resultant benefits and losses incurred by the Company’s life and
health operations. Accordingly, the Company does anticipate incurring higher costs, potentially similar to prior influenza seasons, as it relates to life insurance claims. However, with much of the country sheltering in place over an extended
period, the Company has experienced lower utilization of certain accident and health benefits, particularly in the Medicare supplement line of business. As a result, and although the actual impact cannot be predicted with certainty at this time, the
Company does not expect significant adverse development in total benefits and losses incurred in its life and health operations.
In addition to the information set forth in this report, you should carefully consider the discussions of the COVID-19 pandemic and related economic developments presented in our Annual Report on
Form 10-K for the year ended December 31, 2019, our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020 and June 30, 2020 in other reports we file with the SEC from time to time, all of which could materially affect our business,
financial condition or future results.
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Securities Exchange Act of 1934 (the “Exchange Act”) reports is recorded,
processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief
Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Management necessarily applies its judgment in assessing the costs and benefits of such controls and procedures, which, by their nature, can provide only
reasonable assurance regarding management’s control objectives. The Company’s management, including the Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures can prevent all possible errors
or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. There are inherent limitations in all control systems, including the
realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors or mistakes. Additionally, controls can be circumvented by the intentional acts of one or more persons. The design of any system of
controls is based in part upon certain assumptions about the likelihood of future events, and, while our disclosure controls and procedures are designed to be effective under circumstances where they should reasonably be expected to operate
effectively, there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of the inherent limitations in any control system, misstatements due to possible errors or fraud may
occur and may not be detected. An evaluation was performed under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our
disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this report. Based on that evaluation, our management, including the Chief Executive Officer and Chief
Financial Officer, concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.
There have been no changes in our internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to
materially affect, our internal control over financial reporting.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This report contains and references certain information that constitutes forward-looking statements as that term is defined in the federal securities laws. Statements, to the
extent they are not statements of historical facts, should be considered forward-looking statements, and are subject to various risks and uncertainties. Such forward-looking statements are made based upon management’s current assessments of various
risks and uncertainties, as well as assumptions made in accordance with the “safe harbor” provisions of the federal securities laws. The Company’s actual results could differ materially from the results anticipated in these forward-looking statements
as a result of such risks and uncertainties, including those identified in filings made by the Company from time to time with the Securities and Exchange Commission. In addition, other risks and uncertainties not known by us, or that we currently
determine to not be material, may materially adversely affect our financial condition, results of operations or cash flows. The Company undertakes no obligation to update any forward-looking statement as a result of subsequent developments, changes
in underlying assumptions or facts, or otherwise.
PART II. OTHER INFORMATION
On October 31, 2016, the Board of Directors of the Company approved a plan that allows for the repurchase of up to 750,000 shares of the Company’s common stock (the “Repurchase Plan”) on the open
market or in privately negotiated transactions, as determined by an authorized officer of the Company. Any such repurchases can be made from time to time in accordance with applicable securities laws and other requirements.
Other than pursuant to the Repurchase Plan, no purchases of common stock of the Company were made by or on behalf of the Company during the periods described below.
The table below sets forth information regarding repurchases by the Company of shares of its common stock on a monthly basis during the three month period ended September 30, 2020.
|
Period
|
Total Number
of Shares
Purchased
|
Average
Price Paid
per Share
|
Total Number of
Shares Purchased
as Part of
Publicly
Announced Plans
or Programs
|
Maximum Number
of Shares that
May Yet be
Purchased
Under the Plans
or Programs
|
||||||||||||
|
July 1 – July 31, 2020
|
—
|
$
|
—
|
—
|
325,129
|
|||||||||||
|
August 1 – August 31, 2020
|
—
|
—
|
—
|
325,129
|
||||||||||||
|
September 1 – September 30, 2020
|
—
|
—
|
—
|
325,129
|
||||||||||||
|
Total
|
—
|
$
|
—
|
—
|
||||||||||||
|
Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
101. INS
|
XBRL Instance Document.
|
|
101. SCH
|
XBRL Taxonomy Extension Schema.
|
|
101. CAL
|
XBRL Taxonomy Extension Calculation Linkbase.
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase.
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase.
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase.
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
ATLANTIC AMERICAN CORPORATION
|
||||
|
(Registrant)
|
||||
|
Date: November 10, 2020
|
By:
|
/s/ J. Ross Franklin
|
||
|
J. Ross Franklin
|
||||
|
Vice President and Chief Financial Officer
|
||||
|
(Principal Financial and Accounting Officer)
|
||||
26
EXHIBIT 31.1
CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Hilton H. Howell, Jr., certify that:
| 1. |
I have reviewed this report on Form 10-Q of Atlantic American Corporation;
|
| 2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
| 3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
| 4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
| a) |
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
| b) |
designed such internal control over financial reporting, or
caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes
in accordance with generally accepted accounting principles;
|
| c) |
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report based on such evaluation; and
|
| d) |
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth
fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
| 5. |
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit
committee of registrant’s board of directors (or persons performing the equivalent functions):
|
| a) |
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s
ability to record, process, summarize and report financial information; and
|
| b) |
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
Date: November 10, 2020
|
/s/ Hilton H. Howell, Jr.
|
|
|
Hilton H. Howell, Jr.
|
||
|
President and Chief Executive Officer
|
EXHIBIT 31.2
CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, J. Ross Franklin, certify that:
| 1. |
I have reviewed this report on Form 10-Q of Atlantic American Corporation;
|
| 2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
| 3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
| 4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
| a) |
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
| b) |
designed such internal control over financial reporting, or
caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes
in accordance with generally accepted accounting principles;
|
| c) |
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report based on such evaluation; and
|
| d) |
disclosed in this report any change in the registrant’s internal
control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially
affect, the registrant’s internal control over financial reporting; and
|
| 5. |
The registrant’s other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
|
| a) |
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s
ability to record, process, summarize and report financial information; and
|
| b) |
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
Date: November 10, 2020
|
/s/ J. Ross Franklin
|
|
|
J. Ross Franklin
|
||
|
Vice President and
|
||
|
Chief Financial Officer
|
EXHIBIT 32.1
Certifications Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in connection with the filing of the Quarterly
Report on Form 10-Q of Atlantic American Corporation (the “Company”) for the quarterly period ended September 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the
Company certifies, that, to such officer’s knowledge:
| (1) |
The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and
|
| (2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods
expressed in the Report.
|
|
Date: November 10, 2020
|
/s/ Hilton H. Howell, Jr.
|
|
|
Hilton H. Howell, Jr.
|
||
|
President and Chief Executive Officer
|
||
|
Date: November 10, 2020
|
/s/ J. Ross Franklin
|
|
|
J. Ross Franklin
|
||
|
Vice President and
|
||
|
Chief Financial Officer
|
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its
staff upon request.